UroGen Pharma
URGN
URGN
89 hedge funds and large institutions have $277M invested in UroGen Pharma in 2021 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 36 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
1.66% less ownership
Funds ownership: 65.87% → 64.21% (-1.7%)
39% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 36
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
89
Holding in Top 10
1
Calls
$2.17M
Puts
$1.65M
Top Buyers
| 1 | +$10.1M | |
| 2 | +$4.46M | |
| 3 | +$4.25M | |
| 4 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$3.6M |
| 5 |
BlackRock
New York
|
+$2.75M |
Top Sellers
| 1 | -$14M | |
| 2 | -$3.91M | |
| 3 | -$3.62M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$3.54M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$1.85M |